Cryptosporidium Species in Sohag Governorate

Status Recruiting

Clinical Trial Summary

Cryptosporidium species are increasingly recognized as important enteric pathogens that infect a broad range of hosts including human, domestic and wild animals worldwide, causing asymptomatic or mild-to-severe gastrointestinal disease in their host species. There are 38 species of Cryptosporidium that have been described, going from amphibian parasites to mammals ones, with over 40 genotypes infecting mammals, although Cryptosporidium parvum and Cryptosporidium hominis are the two species predominantly reported in human infections. In Cairo and Sharkyia governorates in Egypt, Cryptosporidium is a common intestinal parasite among children, especially in diarrheic, preschool-aged children, with a predominance of C. hominis indicates anthroponotic rather than zoonotic transmission. Also in the sohag governorate, Cryptosporidium infection is a common intestinal parasite, as in the last five years its prevalence about 35% but there is no study clarify predominant genotype of Cryptosporidium in sohag.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cryptosporidiosis

Clinical Trial Details

NCT number	NCT05208970
Study type	Observational
Source	Sohag University
Contact	Salwa GA Omran, assistant lecturer
Phone	01011154173
Email	salwa.omran@med.sohag.edu.eg
Status	Recruiting
Phase
Start date	March 1, 2022
Completion date	January 2025

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT00057486` - Interleukin 12 (IL-12) for the Treatment of Cryptosporidiosis in AIDS Patients	Phase 1/Phase 2
Completed	`NCT00507871` - Transmission and the Respiratory Tract in Cryptosporidiosis	N/A
Terminated	`NCT00001162` - Parasitic Infections of the Gastrointestinal Tract	N/A
Recruiting	`NCT04332705` - Cryptosporidium Infection and Human Colorectal Cancer
Active, not recruiting	`NCT02764918` - Cryptosporidiosis and Enteropathogens in Bangladesh
Not yet recruiting	`NCT01695304` - Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya	N/A
Terminated	`NCT00004986` - Safety and Effectiveness of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients	Phase 3
Completed	`NCT04103216` - Treatment of Cryptosporidiosis	N/A
Terminated	`NCT03341767` - A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis	Phase 2
Completed	`NCT01699841` - Breast Milk Composition and HIV-exposed/Unexposed Early Infant Growth and Infectious Disease Events	N/A
Active, not recruiting	`NCT00002158` - A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis	N/A
Completed	`NCT00002027` - Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)	N/A
Completed	`NCT00002328` - Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs	N/A
Completed	`NCT00000771` - A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3	Phase 2
Completed	`NCT00000980` - A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea	Phase 1
Completed	`NCT00001018` - A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea	Phase 1
Completed	`NCT00002082` - Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study	N/A
Completed	`NCT00002248` - A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Trial of the Efficacy and Safety of Bovine Anti-Cryptosporidium Immunoglobulin (BACI) in the Treatment of Cryptosporidium Enteritis in AIDS Patients	Phase 1
Terminated	`NCT00001128` - Treatment of Chronic Cryptosporidiosis in AIDS Patients	N/A
Completed	`NCT00001081` - A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium	Phase 2